Skip to content

Preoperative Highflow Nasal Oxygen Application in Cesarean Under General Anesthesia and Its Effects on Newborn.

In the Study; Preoperative Highflow Nasal Oxygen Application in Cesarean Under General Anesthesia and Its Effects on Newborn.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03903003
Enrollment
100
Registered
2019-04-04
Start date
2019-01-01
Completion date
2019-12-31
Last updated
2021-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean Delivery Affecting Newborn

Keywords

high flow nasal oxygen (POİNT)

Brief summary

Preoperative Highflow Nasal Oxygen Application in Cesarean Under General Anesthesia and Its Effects on Newborn.

Detailed description

Patients who will undergo caesarean section under general anesthesia will be included in the study. In the study; preoxygenation is applied to the caesarean sections under general anesthesia in two ways. Group1 includes preoxygenation masked patients.

Interventions

DEVICEhigh flow nasal oxygen device (POİNT)

With POINT device (peri-operative insufflatory nasal therapy); patients are heated at higher flow and applied to humidified oxygen.

DEVICEFace mask

In order to protect the mother from hypoxia, preoxygenation is performed with face mask before induction of anesthesia.

Sponsors

Kocaeli Derince Education and Research Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* over 18 years old; * Patients undergoing elective ceserian operation

Exclusion criteria

* Patients who refuse to participate in the study; * Patients under emergency conditions.

Design outcomes

Primary

MeasureTime frameDescription
durations of stay24 hourscompare the durations of stay in the intensive care unit and in hospital

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026